Neurothera Labs Inc (NTLX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
(Values in thousands)
| 01-2025 | 01-2024 | 01-2023 | 01-2022 | 01-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,079 | 1,220 | 1,281 | 1,361 | 145 |
| TOTAL | $1,081 | $1,221 | $1,284 | $1,372 | $150 |
| Non-Current Assets | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1,081 | $1,221 | $1,284 | $1,372 | $150 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6 | N/A | N/A | N/A | N/A |
| Accrued Expenses | 150 | N/A | N/A | N/A | N/A |
| TOTAL | $156 | $41 | $9 | $18 | $5 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $156 | $41 | $9 | $18 | $5 |
| Shareholders' Equity | |||||
| Common Shares | 1,481 | 1,481 | 1,465 | 1,465 | 150 |
| Retained earnings | -598 | -342 | -238 | -158 | -5 |
| Other shareholders' equity | 42 | 42 | 47 | 47 | 0 |
| TOTAL | $925 | $1,180 | $1,275 | $1,355 | $145 |
| Total Liabilities And Equity | $1,081 | $1,221 | $1,284 | $1,372 | $150 |